Streetbeat News

Products Services

ETHUSD

Former President Donald Trump has launched a third collection of NFTs, the 'MugShot Edition,' which includes digital and physical trading cards, some containing pieces of the suit he wore in his mug shot from an arrest. The NFTs are priced at $99 and can be purchased with credit cards or Wrapped Ethereum (WETH). The collection has 100,000 digital collectibles, a significant increase from previous releases. Buyers of 47 NFTs will receive a physical card and an invitation to a dinner gala at Mar-a-Lago. The suit was authenticated by MEARS, a sports memorabilia authenticator. The NFTs cannot be transferred until December 31, 2024. Trump's previous NFT collections have seen value increases post-launch, with the first collection's floor price at 0.12 ETH and the second at 0.0315 ETH.

Portfolio Pulse from Chris Katje

December 12, 2023 | 8:33 pm

INCY

Incyte Corporation (NASDAQ:INCY) stock has seen a significant increase, rising approximately 13% since Monday. The surge follows a period of consolidation over November and comes after the company's third-quarter financial results and 2023 net product revenue guidance. Additionally, the stock's price target has varied between $63 to $98 in the past month. The recent spike is attributed to the announcement of full results from the Phase 2 AGAVE-201 trial of axatilimab, presented at the American Society of Hematology Annual Meeting 2023. At the time of publication, INCY shares were up 8.75% at $62.03.

Portfolio Pulse from Ryan Gustafson

December 12, 2023 | 8:33 pm

NFLX

Netflix has publicly released viewership data for all its shows and films for the first time, providing transparency into the popularity of its content. This move could help Netflix attract new talent and partnerships by showcasing the success of its platform.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 7:31 pm

MYMD

MyMD Pharmaceuticals has received a notice of allowance for its U.S. patent application 17/851,862, which covers a method of treating diseases of the visual system. This development could potentially enhance the company's intellectual property portfolio and provide a competitive edge in the market for treatments related to eye diseases.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 7:25 pm

ACHV

ADTX

CCCC

GGE

ICVX

JCI

ORCL

U.S. stocks closed higher with the Dow Jones gaining over 100 points. Materials shares rose by 0.5%, while energy shares fell by 1.7%. Johnson Controls reported Q4 results with sales growth of 2.7% Y/Y to $6.91 billion, missing estimates. Aditxt's shares surged 64% after agreeing to acquire Evofem Biosciences. C4 Therapeutics shares jumped 108% due to a collaboration agreement with Merck & Co. Icosavax shares increased 48% after AstraZeneca's acquisition announcement. Conversely, Achieve Life Sciences shares fell 42%, Oracle shares dropped 12%, and Green Giant shares declined 44%. Crude oil was down 4.1%, and gold slightly increased by 0.1%.

Portfolio Pulse from Avi Kapoor

December 12, 2023 | 7:23 pm

HOOD

SCHW

SPY

SQQQ

TQQQ

Retail investing has surged in 2023, with a significant number of new brokerage accounts opened since 2020. Despite a drop in users for platforms like Robinhood, many investors have moved to brokers like Fidelity and Charles Schwab. Retail trading volume hit a record $1.51 billion daily in February 2023. Public's data shows retail investors diversifying into ETFs and fixed-income assets, with ProShares UltraPro Short QQQ ETF, ProShares UltraPro QQQ, and SPDR S&P 500 ETF Trust being the top traded ETFs.

Portfolio Pulse from Natan Ponieman

December 12, 2023 | 7:20 pm

General Motors (GM) and Komatsu Ltd. have announced a partnership to co-develop a hydrogen fuel cell power module. This module is intended for use in Komatsu's 930E electric drive mining truck. The collaboration aims to integrate GM's advanced technology into Komatsu's vehicles to enhance their efficiency and environmental performance.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 7:08 pm

ABBV

EOLS

RVNC

SUPN

Public Citizen, a consumer advocacy group, has petitioned the FDA to enforce stronger warnings on botulinum toxin injections like AbbVie's Botox, Revance Therapeutics' Daxxify, Evolus' Jeuveau, and Supernus Pharmaceuticals' Myobloc. The group cites over 5,400 adverse event reports and calls for clear labeling of the risk of systemic iatrogenic botulism, which can cause muscle paralysis. The FDA is set to review the petition.

Portfolio Pulse from Vandana Singh

December 12, 2023 | 7:04 pm

HEI

TDG

VSEC

William Blair analyst Louie DiPalma initiated coverage on Boeing (BA), Transdigm Group (TDG), and Heico Corporation (HEI), with an Outperform rating, and reiterated the same rating for VSE Corporation (VSEC). DiPalma predicts an aftermarket supercycle in the aviation industry due to increased travel and aging aircraft fleets. Boeing is expected to resume sales of B737 MAX to Chinese airlines. TransDigm is anticipated to return to its historical average premium valuation, and Heico is expected to see at least a 21% upside due to its unique FAA-PMA parts production method.

Portfolio Pulse from Shivani Kumaresan

December 12, 2023 | 6:52 pm

BNTX

MRK

MRNA

PFE

Moderna Inc (NASDAQ:MRNA) is restructuring its operating model to prioritize sales of its COVID-19 vaccine, Spikevax, and the launch of its RSV vaccine in 2024. CEO Stephane Bancel will oversee sales and marketing, while President Stephen Hoge will handle pipeline commercial strategy. Arpa Garay is expected to leave the company. Moderna and Merck & Co Inc (NYSE:MRK) initiated a Phase 3 trial for a cancer therapy. MRNA shares fell 5.54% to $77.47. A patent victory for Pfizer Inc (NYSE:PFE)/BioNTech SE (NASDAQ:BNTX) was also noted.

Portfolio Pulse from Vandana Singh

December 12, 2023 | 6:38 pm